I guess that's logical. It's known that Marxe wanted to sell, but obviously they aren't expecting great news real soon. It would be a great show of support that a fund wanted it. The timing, after the close on Friday before the end of the year, makes me think you are spot on, a prearranged sale/purchase.
Bought my 500 sh back. Sold at 12.78 this a.m., bought back at 11.58. Wish I had done better on the swing. Caught the afternoon blip up, then down, then up,...
I might as we'll add that I'm sure we will have another big partnership by then, so the stakes will be even higher at about $3.50+ per share. Maybe the partnership will be such as to give us a better clue on effectiveness. That would save my fingernails and about $100K.
My one BIG concern (long 30K) is that VGX-3100 IS shaping up to be a binary event. Many applications, but none so important to stock price as next interim. No one can help me with this. It's called risk.
Thanks for the info. I plan to buy back in for the long term, maybe even this afternoon. Couldn't resist selling this morning's surge.
EDAP needs a royalty model, not just machine sales in US to command that kind of price. I think our best hope would be a nice, juicy buyout after approval, say $20.
This is a buy opportunity, not a sell. I'm maxed out, or I would buy more. Will go up at least 50 percent in the next year.
Australopithecus has been sited! New name is urkt302, who thinks 9 person company will cure major diseases. CEO has business and psych degree. Wrong skill set for this business.
Great! I wondered what douchebag would bite on my post. I got a hit. Congratulations, your are the winner. Call me when Pran cures A, P, H, or MS.
9 person company in Australia valued at $256M market cap is going to cure MS and Huntington's, while the world's greatest drug companies will fail. Therefore I should invest my hard-earned cash in this stock Ponzi. Right?
Not sure a confidence was violated by posting her email.I'm sure she wrote her response knowing that it would likely become public knowledge. No big deal. I appreciate the insight she provided.
At 5.43 a few minutes ago. I don't like AF's attitude, but he was right on CLSN. If I had listened, I would be 12K richer. I'll let this go a few weeks and see how it settles out. Might be a better buy at $7 than 5.43, if we have a better sense of the efficacy. Too volatile now. But, if it drops into the mid-4's, "I'll be bek."